nach oben

Journal of Pediatric Neuropsychology

Erschienen in:

01.06.2016

Neuropsychological Functioning in Individuals with Noonan Syndrome: a Systematic Literature Review with Educational and Treatment Recommendations

verfasst von: Elizabeth I. Pierpont

Erschienen in: Journal of Pediatric Neuropsychology | Ausgabe 1-2/2016

Einloggen, um Zugang zu erhalten

Abstract

Noonan syndrome (NS) is a relatively common genetic syndrome with variable features including short stature, congenital heart disease, distinctive facial characteristics, skeletal anomalies, and varying degrees of developmental delay. NS is caused by gene mutations in a cellular signaling pathway that is essential for typical growth and development. Research in the past few decades has revealed that individuals with NS have highly variable neurocognitive and behavioral outcomes. To a certain extent, variability in cognitive functioning depends on the particular gene where a mutation is found; additionally, factors related to medical severity and environmental effects contribute substantially to outcomes. This article contains a systematic review of research on neuropsychological features of NS, including cognition, motor development, language, memory, attention, visual perception, adaptive behavior, social skills, and mental health concerns. Given the wide variety of possible cognitive and behavioral complications associated with NS, it is recommended that clinical neuropsychological evaluation of cognitive, adaptive, and psychological domains of functioning should be standard of care for all individuals with NS. Suggested considerations for assessment of individuals with NS are provided. The paper concludes with recommendations for educational and therapeutic interventions, as well as suggestions for future research directions.

Acosta, M. T., Kardel, P. G., Walsh, K. S., Rosenbaum, K. N., Gioia, G. A., & Packer, R. J. (2011). Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study. Pediatric Neurology, 45(4), 241–245. doi:10.1016/j.pediatrneurol.2011.06.016.PubMedCrossRef

Acosta, M. T., Bearden, C. E., Castellanos, F. X., Cutting, L., Elgersma, Y., Gioia, G., et al. (2012). The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research. American Journal of Medical Genetics. Part A, 158A(9), 2225–2232. doi:10.1002/ajmg.a.35535.PubMedCrossRef

Addissie, Y. A., Kotecha, U., Hart, R. A., Martinez, A. F., Kruszka, P., & Muenke, M. (2015). Craniosynostosis and Noonan syndrome with KRAS mutations: expanding the phenotype with a case report and review of the literature. American Journal of Medical Genetics. Part A. doi:10.1002/ajmg.a.37259.PubMed

Adviento, B., Corbin, I. L., Widjaja, F., Desachy, G., Enrique, N., Rosser, T., et al. (2014). Autism traits in the RASopathies. Journal of Medical Genetics, 51(1), 10–20. doi:10.1136/jmedgenet-2013-101951.PubMedPubMedCentralCrossRef

Alfieri, P., Cesarini, L., Zampino, G., Pantaleoni, F., Selicorni, A., Salerni, A., et al. (2008). Visual function in Noonan and LEOPARD syndrome. Neuropediatrics, 39(6), 335–340. doi:10.1055/s-0029-1216354.PubMedCrossRef

Alfieri, P., Cesarini, L., De Rose, P., Ricci, D., Selicorni, A., Menghini, D., et al. (2011a). Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity. American Journal of Medical Genetics. Part A, 155A(10), 2459–2464. doi:10.1002/ajmg.a.34229.PubMedCrossRef

Alfieri, P., Cesarini, L., Mallardi, M., Piccini, G., Caciolo, C., Leoni, C., et al. (2011b). Long term memory profile of disorders associated with dysregulation of the RAS-MAPK signaling cascade. Behavior Genetics, 41(3), 423–429. doi:10.1007/s10519-011-9446-5.PubMedCrossRef

Alfieri, P., Piccini, G., Caciolo, C., Perrino, F., Gambardella, M. L., Mallardi, M., et al. (2014). Behavioral profile in RASopathies. American Journal of Medical Genetics. Part A. doi:10.1002/ajmg.a.36374.PubMed

Allanson, J. E., Anneren, G., Aoki, Y., Armour, C. M., Bondeson, M. L., Cave, H., et al. (2011). Cardio-facio-cutaneous syndrome: does genotype predict phenotype? American Journal of Medical Genetics. Part C, 157(2), 129–135. doi:10.1002/ajmg.c.30295.CrossRef

American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders, fourth edition-text revision. Washington, DC: Author.

Aoki, Y., Niihori, T., Banjo, T., Okamoto, N., Mizuno, S., Kurosawa, K., et al. (2013). Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. American Journal of Human Genetics, 93(1), 173–180. doi:10.1016/j.ajhg.2013.05.021.PubMedPubMedCentralCrossRef

Arvaniti, A., Samakouri, M., Keskeridou, F., & Veletza, S. (2014). Concurrence of anorexia nervosa and Noonan syndrome. European Eating Disorders Review, 22(1), 83–85. doi:10.1002/erv.2261.PubMedCrossRef

Bertola, D. R., Pereira, A. C., de Oliveira, P. S., Kim, C. A., & Krieger, J. E. (2004). Clinical variability in a Noonan syndrome family with a new PTPN11 gene mutation. American Journal of Medical Genetics. Part A, 130A(4), 378–383. doi:10.1002/ajmg.a.30270.PubMedCrossRef

Binder, G., Grathwol, S., von Loeper, K., Blumenstock, G., Kaulitz, R., Freiberg, C., et al. (2012). Health and quality of life in adults with Noonan syndrome. The Journal of Pediatrics, 161(3), 501–505. doi:10.1016/j.jpeds.2012.02.043. e501.PubMedCrossRef

Cesarini, L., Alfieri, P., Pantaleoni, F., Vasta, I., Cerutti, M., Petrangeli, V., et al. (2009). Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade. American Journal of Medical Genetics. Part A, 149A(2), 140–146. doi:10.1002/ajmg.a.32488.PubMedCrossRef

Chromik, L. C., Quintin, E. M., Lepage, J. F., Hustyi, K. M., Lightbody, A. A., & Reiss, A. L. (2015). The influence of hyperactivity, impulsivity, and attention problems on social functioning in adolescents and young adults with fragile X syndrome. Journal of Attention Disorders. doi:10.1177/1087054715571739.PubMed

Cielo, C. M., & Marcus, C. L. (2015). Obstructive sleep apnoea in children with craniofacial syndromes. Paediatric Respiratory Reviews, 16(3), 189–196. doi:10.1016/j.prrv.2014.11.003.PubMedCrossRef

Colquitt, J. L., & Noonan, J. A. (2014). Cardiac findings in Noonan syndrome on long-term follow-up. Congenital Heart Disease, 9(2), 144–150. doi:10.1111/chd.12102.PubMedCrossRef

Constantino, J., & Gruber, C. (2005). The Social Responsiveness Scale Manual. Los Angeles, CA: Western Psychological Services.

Cordeddu, V., Di Schiavi, E., Pennacchio, L. A., Ma'ayan, A., Sarkozy, A., Fodale, V., et al. (2009). Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nature Genetics, 41(9), 1022–1026. doi:10.1038/ng.425.PubMedPubMedCentralCrossRef

Costa, R. M., Yang, T., Huynh, D. P., Pulst, S. M., Viskochil, D. H., Silva, A. J., et al. (2001). Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nature Genetics, 27(4), 399–405. doi:10.1038/86898.PubMedCrossRef

Costa, R. M., Federov, N. B., Kogan, J. H., Murphy, G. G., Stern, J., Ohno, M., et al. (2002). Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature, 415(6871), 526–530. doi:10.1038/nature711.PubMedCrossRef

Cutting, L. E., & Levine, T. M. (2010). Cognitive profile of children with neurofibromatosis and reading disabilities. Child Neuropsychology, 16(5), 417–432. doi:10.1080/09297041003761985.PubMedPubMedCentralCrossRef

Dauvilliers, Y., Stal, V., Abril, B., Coubes, P., Bobin, S., Touchon, J., et al. (2007). Chiari malformation and sleep related breathing disorders. Journal of Neurology, Neurosurgery and Psychiatry, 78(12), 1344–1348. doi:10.1136/jnnp.2006.108779.PubMedPubMedCentralCrossRef

Davis, S., & Laroche, S. (2006). Mitogen-activated protein kinase/extracellular regulated kinase signalling and memory stabilization: a review. Genes, Brain, and Behavior, 5(2), 61–72. doi:10.1111/j.1601-183X.2006.00230.x.PubMedCrossRef

Diggs-Andrews, K. A., & Gutmann, D. H. (2013). Modeling cognitive dysfunction in neurofibromatosis-1. Trends in Neurosciences, 36(4), 237–247. doi:10.1016/j.tins.2012.12.002.PubMedPubMedCentralCrossRef

Elliott, C. (1990). Differential Ability Scales. San Antonio, TX: The Psychological Corporation.

Forehand, R., Jones, D. J., & Parent, J. (2013). Behavioral parenting interventions for child disruptive behaviors and anxiety: what's different and what's the same. Clinical Psychology Review, 33(1), 133–145. doi:10.1016/j.cpr.2012.10.010.PubMedPubMedCentralCrossRef

Forgeron, P. A., King, S., Stinson, J. N., McGrath, P. J., MacDonald, A. J., & Chambers, C. T. (2010). Social functioning and peer relationships in children and adolescents with chronic pain: a systematic review. Pain Research and Management, 15(1), 27–41.PubMedPubMedCentralCrossRef

Galasso, C., Lo-Castro, A., Di Carlo, L., Pitzianti, M. B., D'Agati, E., Curatolo, P., et al. (2014). Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)? Journal of Child Neurology. doi:10.1177/0883073813517001.PubMed

Galuschka, K., Ise, E., Krick, K., & Schulte-Korne, G. (2014). Effectiveness of treatment approaches for children and adolescents with reading disabilities: a meta-analysis of randomized controlled trials. PloS One, 9(2), e89900. doi:10.1371/journal.pone.0089900.PubMedPubMedCentralCrossRef

Gauthier, A. S., Furstoss, O., Araki, T., Chan, R., Neel, B. G., Kaplan, D. R., et al. (2007). Control of CNS cell-fate decisions by SHP-2 and its dysregulation in Noonan syndrome. Neuron, 54(2), 245–262. doi:10.1016/j.neuron.2007.03.027.PubMedPubMedCentralCrossRef

Griffiths, R., & Huntley, M. (1996). The Griffiths Mental Development Scales: from birth to 2 years. The Test Agency Ltd: Henley-on-Thames.

Gripp, K. W., Zand, D. J., Demmer, L., Anderson, C. E., Dobyns, W. B., Zackai, E. H., et al. (2013). Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis. American Journal of Medical Genetics. Part A, 161A(10), 2420–2430. doi:10.1002/ajmg.a.36098.PubMed

Isenberg, J. C., Templer, A., Gao, F., Titus, J. B., & Gutmann, D. H. (2012). Attention skills in children with neurofibromatosis type 1. Journal of Child Neurology. doi:10.1177/0883073812439435.PubMed

Keh, Y. S., Abernethy, L., & Pettorini, B. (2013). Association between Noonan syndrome and Chiari I malformation: a case-based update. Child's Nervous System, 29(5), 749–752. doi:10.1007/s00381-012-2000-9.PubMedCrossRef

Khirani, S., Leboulanger, N., Ramirez, A., & Fauroux, B. (2012). Life-threatening obstructive sleep apnea caused by adenoid hypertrophy in an infant with Noonan syndrome. Case Reports in Pediatrics, 2012, 514514. doi:10.1155/2012/514514.PubMedPubMedCentralCrossRef

Koudova, M., Seemanova, E., & Zenker, M. (2009). Novel BRAF mutation in a patient with LEOPARD syndrome and normal intelligence. European Journal of Medical Genetics, 52(5), 337–340. doi:10.1016/j.ejmg.2009.04.006.PubMedCrossRef

Kover, S. T., Pierpont, E. I., Kim, J. S., Brown, W. T., & Abbeduto, L. (2013). A neurodevelopmental perspective on the acquisition of nonverbal cognitive skills in adolescents with fragile X syndrome. Developmental Neuropsychology, 38(7), 445–460. doi:10.1080/87565641.2013.820305.PubMedCrossRef

Krab, L. C., de Goede-Bolder, A., Aarsen, F. K., Pluijm, S. M., Bouman, M. J., van der Geest, J. N., et al. (2008). Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. Journal of the American Medical Association, 300(3), 287–294. doi:10.1001/jama.300.3.287.PubMedPubMedCentralCrossRef

Kratz, C. P., Zampino, G., Kriek, M., Kant, S. G., Leoni, C., Pantaleoni, F., et al. (2009). Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations. American Journal of Medical Genetics. Part A, 149A(5), 1036–1040. doi:10.1002/ajmg.a.32786.PubMedCrossRef

Kratz, C. P., Rapisuwon, S., Reed, H., Hasle, H., & Rosenberg, P. S. (2011). Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes. American Journal of Medical Genetics. Part C, 157C(2), 83–89. doi:10.1002/ajmg.c.30300.CrossRef

Lee, N. B., Kelly, L., & Sharland, M. (1992). Ocular manifestations of Noonan syndrome. Eye, 6(Pt 3), 328–334. doi:10.1038/eye.1992.66.PubMedCrossRef

Lee, D. A., Portnoy, S., Hill, P., Gillberg, C., Patton, M. A., Allanson, J., et al. (2005). Psychological profile of children with Noonan syndrome. Developmental Medicine and Child Neurology, 47(1), 35–38.PubMedCrossRef

Lee, B. H., Kim, J. M., Jin, H. Y., Kim, G. H., Choi, J. H., & Yoo, H. W. (2011). Spectrum of mutations in Noonan syndrome and their correlation with phenotypes. The Journal of Pediatrics, 159(6), 1029–1035. doi:10.1016/j.jpeds.2011.05.024.PubMedCrossRef

Lee, Y. S., Ehninger, D., Zhou, M., Oh, J. Y., Kang, M., Kwak, C., et al. (2014). Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome. Nature Neuroscience, 17(12), 1736–1743. doi:10.1038/nn.3863.PubMedPubMedCentralCrossRef

Leu, R. M. (2015). Sleep related breathing disorders and the Chiari 1 malformation. Chest. doi:10.1378/chest.14-3090.PubMed

Lindstrom, K., Winbladh, B., Haglund, B., & Hjern, A. (2007). Preterm infants as young adults: a Swedish national cohort study. Pediatrics, 120(1), 70–77. doi:10.1542/peds.2006-3260.PubMedCrossRef

Lion-Francois, L., Gueyffier, F., Mercier, C., Gerard, D., Herbillon, V., Kemlin, I., et al. (2014). The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial. Orphanet Journal of Rare Diseases, 9(1), 142. doi:10.1186/s13023-014-0142-4.PubMedPubMedCentralCrossRef

Lo-Castro, A., D'Agati, E., & Curatolo, P. (2011). ADHD and genetic syndromes. Brain and Development, 33(6), 456–461. doi:10.1016/j.braindev.2010.05.011.PubMedCrossRef

Luckasson, R., Borthwick-Duffy, S., Buntinx, W. H. E., Coulter, D. L., Craig, E. M., Schalock, R. L., et al. (2002). Mental retardation: definition, classification, and systems of supports (10th ed.). Washington, DC US: American Association on Mental Retardation.

Mainberger, F., Zenker, M., Jung, N. H., Delvendahl, I., Brandt, A., Freudenberg, L., et al. (2013). Impaired motor cortex plasticity in patients with Noonan syndrome. Clinical Neurophysiology, 124(12), 2439–2444. doi:10.1016/j.clinph.2013.04.343.PubMedCrossRef

Marin, L., da Silva, F. T., de Sa, L. C., Brasil, A. S., Pereira, A., Furquim, I. M., et al. (2012). Ocular manifestations of Noonan syndrome. Ophthalmic Genetics, 33(1), 1–5. doi:10.3109/13816810.2011.593606.CrossRef

Marino, B. S., Lipkin, P. H., Newburger, J. W., Peacock, G., Gerdes, M., Gaynor, J. W., et al. (2012). Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation, 126(9), 1143–1172. doi:10.1161/CIR.0b013e318265ee8a.PubMedCrossRef

Mautner, V. F., Kluwe, L., Thakker, S. D., & Leark, R. A. (2002). Treatment of ADHD in neurofibromatosis type 1. Developmental Medicine and Child Neurology, 44(3), 164–170.PubMedCrossRef

Mendez, H. M., & Opitz, J. M. (1985). Noonan syndrome: a review. American Journal of Medical Genetics, 21(3), 493–506. doi:10.1002/ajmg.1320210312.PubMedCrossRef

Moster, D., Lie, R. T., & Markestad, T. (2008). Long-term medical and social consequences of preterm birth. The New England Journal of Medicine, 359(3), 262–273. doi:10.1056/NEJMoa0706475.PubMedCrossRef

Neri, G., Allanson, J., & Kavamura, M. I. (2008). No reason yet to change diagnostic criteria for Noonan, Costello and cardio-facio-cutaneous syndromes. Journal of Medical Genetics, 45(12), 832. doi:10.1136/jmg.2008.063263.PubMedCrossRef

Nishi, E., Mizuno, S., Nanjo, Y., Niihori, T., Fukushima, Y., Matsubara, Y., et al. (2015). A novel heterozygous MAP2K1 mutation in a patient with Noonan syndrome with multiple lentigines. American Journal of Medical Genetics. Part A, 167(2), 407–411. doi:10.1002/ajmg.a.36842.CrossRef

Noonan, J. A. (2005). Noonan syndrome. In S. Goldstein & C. R. Reynolds (Eds.), Handbook of neurodevelopmental and genetic disorders in adults (pp. 308–319). New York: Guilford Press.

Noonan Syndrome Guideline Development Group (2010). Management of Noonan syndrome: a clinical guideline. Resource document. Rasopathies Network. https://rasopathiesnet.org/wp-content/uploads/2014/01/265_Noonan_Guidelines.pdf. Accessed 8 Aug 2015.

Noonan, J. A., & Ehmke, D. A. (1963). Associated noncardiac malformations in children with congenital heart disease. Journal of Pediatrics, 63, 468–470.

Nystrom, A. M., Ekvall, S., Berglund, E., Bjorkqvist, M., Braathen, G., Duchen, K., et al. (2008). Noonan and cardio-facio-cutaneous syndromes: two clinically and genetically overlapping disorders. Journal of Medical Genetics, 45, 500–506. doi:10.1136/jmg.2008.057653.PubMedCrossRef

Pagani, M. R., Oishi, K., Gelb, B. D., & Zhong, Y. (2009). The phosphatase SHP2 regulates the spacing effect for long-term memory induction. Cell, 139(1), 186–198. doi:10.1016/j.cell.2009.08.033.PubMedPubMedCentralCrossRef

Payne, J. M., Hyman, S. L., Shores, E. A., & North, K. N. (2011). Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Child Neuropsychology, 17(4), 313–329. doi:10.1080/09297049.2010.542746.PubMedCrossRef

Pierpont, E. I., Pierpont, M. E., Mendelsohn, N. J., Roberts, A. E., Tworog-Dube, E., & Seidenberg, M. S. (2009). Genotype differences in cognitive functioning in Noonan syndrome. Genes, Brain and Behavior, 8(3), 275–282. doi:10.1111/j.1601-183X.2008.00469.x.CrossRef

Pierpont, E. I., Ellis Weismer, S., Roberts, A. E., Tworog-Dube, E., Pierpont, M. E., Mendelsohn, N. J., et al. (2010a). The language phenotype of children and adolescents with Noonan syndrome. Journal of Speech, Language, and Hearing Research, 53(4), 917–932. doi:10.1044/1092-4388(2009/09-0046).PubMedPubMedCentralCrossRef

Pierpont, E. I., Pierpont, M. E., Mendelsohn, N. J., Roberts, A. E., Tworog-Dube, E., Rauen, K. A., et al. (2010b). Effects of germline mutations in the Ras/MAPK signaling pathway on adaptive behavior: cardiofaciocutaneous syndrome and Noonan syndrome. American Journal of Medical Genetics. Part A, 152A(3), 591–600. doi:10.1002/ajmg.a.33268.PubMedPubMedCentralCrossRef

Pierpont, E. I., Tworog-Dube, E., & Roberts, A. E. (2013). Learning and memory in children with Noonan syndrome. American Journal of Medical Genetics. Part A, 161(9), 2250–2257. doi:10.1002/ajmg.a.36075.CrossRef

Pierpont, E. I., Tworog-Dube, E., & Roberts, A. E. (2015). Attention skills and executive functioning in children with Noonan syndrome and their unaffected siblings. Developmental Medicine and Child Neurology, 57(4), 385–392. doi:10.1111/dmcn.12621.PubMedCrossRef

Piers, E., & Harris, D. (1989). The Pier-Harris Children's Self-Concept Scale. Los Angeles, CA: Western Psychological Services.

Plotkin, S. R., Blakeley, J. O., Dombi, E., Fisher, M. J., Hanemann, C. O., Walsh, K. S., et al. (2013). Achieving consensus for clinical trials: the REiNS International Collaboration. Neurology, 81(21 Suppl 1), S1–5. doi:10.1212/01.wnl.0000435743.49414.b6.PubMedPubMedCentralCrossRef

Powell, K. B., & Voeller, K. K. (2004). Prefrontal executive function syndromes in children. Journal of Child Neurology, 19(10), 785–797.PubMed

Qiu, W., Yin, S., & Stucker, F. (1998). Audiologic manifestations of Noonan syndrome. Otolaryngology - Head and Neck Surgery, 118(3, Pt. 1), 319–323.PubMedCrossRef

Rauen, K. A. (2013). The RASopathies. Annual Review of Genomics and Human Genetics, 14, 355–369. doi:10.1146/annurev-genom-091212-153523.PubMedPubMedCentralCrossRef

Reichow, B., Steiner, A. M., & Volkmar, F. (2013). Cochrane review: social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD). Evidence-based Child Health, 8(2), 266–315. doi:10.1002/ebch.1903.PubMedCrossRef

Rey, A. (1941). L'examen psychologique dans les cas d'encephalopathie traumatique. Archives de Psychologie, 28, 286–340.

Roberts, A. E., Araki, T., Swanson, K. D., Montgomery, K. T., Schiripo, T. A., Joshi, V. A., et al. (2007). Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nature Genetics, 39(1), 70–74. doi:10.1038/ng1926.PubMedCrossRef

Roberts, A. E., Allanson, J. E., Tartaglia, M., & Gelb, B. D. (2013). Noonan syndrome. Lancet, 381(9863), 333–342. doi:10.1016/S0140-6736(12)61023-X.PubMedPubMedCentralCrossRef

Robins, D., Fein, D., Barton, M., & Green, J. (2001). The Modified Checklist for Autism in Toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. Journal of Autism and Developmental Disorders, 31, 131–144.PubMedCrossRef

Romano, A. A., Allanson, J. E., Dahlgren, J., Gelb, B. D., Hall, B., Pierpont, M. E., et al. (2010). Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics, 126(4), 746–759. doi:10.1542/peds.2009-3207.PubMedCrossRef

Rowbotham, I., Pit-ten Cate, I. M., Sonuga-Barke, E. J., & Huijbregts, S. C. (2009). Cognitive control in adolescents with neurofibromatosis type 1. Neuropsychology, 23(1), 50–60. doi:10.1037/a0013927.PubMedCrossRef

Rutter, M., Bailey, A., & Lord, C. (2003). Social communication questionnaire. Los Angeles, CA: Western Psychological Services.

Samuels, I. S., Saitta, S. C., & Landreth, G. E. (2009). MAP'ing CNS development and cognition: an ERKsome process. Neuron, 61(2), 160–167. doi:10.1016/j.neuron.2009.01.001.PubMedPubMedCentralCrossRef

Sandberg, D. E. (2011). Short stature: psychosocial interventions. Hormone Research in Pædiatrics, 76(Suppl 3), 29–32. doi:10.1159/000330151.PubMedCrossRef

Sarimski, K. (2000). Developmental and behavioural phenotype in Noonan syndrome? Genetic Counseling, 11(4), 383–390.PubMed

Sarkozy, A., Digilio, M. C., & Dallapiccola, B. (2008). LEOPARD syndrome. Orphanet Journal of Rare Diseases, 3, 13. doi:10.1186/1750-1172-3-13.PubMedPubMedCentralCrossRef

Sarkozy, A., Carta, C., Moretti, S., Zampino, G., Digilio, M. C., Pantaleoni, F., et al. (2009). Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Human Mutation, 30(4), 695–702. doi:10.1002/humu.20955.PubMedPubMedCentralCrossRef

Scantlebury, N., Cunningham, T., Dockstader, C., Laughlin, S., Gaetz, W., Rockel, C., et al. (2014). Relations between white matter maturation and reaction time in childhood. Journal of the International Neuropsychological Society, 20(1), 99–112. doi:10.1017/S1355617713001148.PubMedCrossRef

Schubbert, S., Zenker, M., Rowe, S., Boll, S., Klein, C., Bollag, G., et al. (2006). Germline KRAS mutations cause Noonan syndrome. Nature Genetics, 38(3), 331–336. doi:10.1038/ng1748.PubMedCrossRef

Shadfar, S., Drake, A. F., Vaughn, B. V., & Zdanski, C. J. (2012). Pediatric airway abnormalities: evaluation and management. Oral and Maxillofacial Surgery Clinics of North America, 24(3), 325–336. doi:10.1016/j.coms.2012.04.005.PubMedCrossRef

Shah, N., Rodriguez, M., Louis, D. S., Lindley, K., & Milla, P. J. (1999). Feeding difficulties and foregut dysmotility in Noonan's syndrome. Archives of Disease in Childhood, 81(1), 28–31.PubMedPubMedCentralCrossRef

Sharland, M., Burch, M., McKenna, W., & Paton, M. (1992). A clinical study of Noonan Syndrome. Archives of Disease in Childhood, 67(2), 178–183.PubMedPubMedCentralCrossRef

Shaw, A. C., Kalidas, K., Crosby, A. H., Jeffery, S., & Patton, M. A. (2007). The natural history of Noonan syndrome: a long-term follow-up study. Archives of Disease in Childhood, 92(2), 128–132. doi:10.1136/adc.2006.104547.PubMedPubMedCentralCrossRef

Sheslow, D., & Adams, W. (2003). Wide range assessment of memory and learning (2nd ed.). Lutz, FL: Psychological Assessment Resources, Inc.

Shilyansky, C., Karlsgodt, K. H., Cummings, D. M., Sidiropoulou, K., Hardt, M., James, A. S., et al. (2010a). Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proceedings of the National Academy of Sciences of the United States of America, 107(29), 13141–13146. doi:10.1073/pnas.1004829107.PubMedPubMedCentralCrossRef

Shilyansky, C., Lee, Y. S., & Silva, A. J. (2010b). Molecular and cellular mechanisms of learning disabilities: a focus on NF1. Annual Review of Neuroscience, 33, 221–243. doi:10.1146/annurev-neuro-060909-153215.PubMedPubMedCentralCrossRef

Smpokou, P., Tworog-Dube, E., Kucherlapati, R. S., & Roberts, A. E. (2012). Medical complications, clinical findings, and educational outcomes in adults with Noonan syndrome. American Journal of Medical Genetics. Part A, 158A(12), 3106–3111. doi:10.1002/ajmg.a.35639.PubMedCrossRef

Smpokou, P., Zand, D. J., Rosenbaum, K. N., & Summar, M. L. (2015). Malignancy in Noonan syndrome and related disorders. Clinical Genetics. doi:10.1111/cge.12568.PubMed

Storch, E. A., & Ledley, D. R. (2005). Peer victimization and psychosocial adjustment in children: current knowledge and future directions. Clinical Pediatrics, 44(1), 29–38.PubMedCrossRef

Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., et al. (2001). Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nature Genetics, 29(4), 465–468. doi:10.1038/ng772.PubMedCrossRef

Tartaglia, M., Kalidas, K., Shaw, A., Song, X., Musat, D. L., van der Burgt, I., et al. (2002). PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. American Journal of Human Genetics, 70(6), 1555–1563. doi:10.1086/340847.PubMedPubMedCentralCrossRef

Tartaglia, M., Pennacchio, L. A., Zhao, C., Yadav, K. K., Fodale, V., Sarkozy, A., et al. (2007). Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nature Genetics, 39(1), 75–79. doi:10.1038/ng1939.PubMedCrossRef

Tartaglia, M., Gelb, B. D., & Zenker, M. (2011). Noonan syndrome and clinically related disorders. Best practice and research. Clinical Endocrinology and Metabolism, 25(1), 161–179. doi:10.1016/j.beem.2010.09.002.PubMedPubMedCentral

Tiffen, J. (1968). Purdue pegboard test. Chicago: Science Research Associates.

van der Burgt, I., Thoonen, G., Roosenboom, N., Assman-Hulsmans, C., Gabreels, F., Otten, B., et al. (1999). Patterns of cognitive functioning in school-aged children with Noonan syndrome associated with variability in phenotypic expression. Journal of Pediatrics, 135(6), 707–713.PubMedCrossRef

van der Steene, G., van Haasen, P., de Bruyn, E., Coetsier, P., Pijl, Y., Poortinga, Y., et al. (1986). Wechsler Intelligence Scale for Children-Revised (Dutch version). Lisse: Swets & Zeitlinger.

van der Vaart, T., Plasschaert, E., Rietman, A. B., Renard, M., Oostenbrink, R., Vogels, A., et al. (2013). Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial. Lancet Neurology, 12(11), 1076–1083. doi:10.1016/S1474-4422(13)70227-8.PubMedCrossRef

Verhoeven, W., Wingbermuhle, E., Egger, J., Van der Burgt, I., & Tuinier, S. (2008). Noonan syndrome: psychological and psychiatric aspects. American Journal of Medical Genetics. Part A, 146A(2), 191–196. doi:10.1002/ajmg.a.32115

Wechsler, D. (1974). Wechsler Intelligence Scale for Children, Revised. New York: Psychological Corporation.

Wechsler, D. (1989). Wechsler Preschool and Primary Scale of Intelligence, Revised. San Antonio, TX: The Psychological Corporation.

Wechsler, D. (1997). Wechsler Adult Intelligence Scale (3rd ed.). San Antonio, TX: Psychological Corporation.

Wechsler, D. (1999). Wechsler Abbreviated Scale of Intelligence. San Antonio: Pearson.

Willcutt, E., Sonuga-Barke, E., Nigg, J., & Sergeant, J. (2008). Recent developments in neuropsychological models of childhood psychiatric disorders. In T. Banaschewski, & L. Rohde (Eds.), Biological child psychiatry. Recent trends and developments (Vol. 24, pp. 195–226, Advances in Biological Psychiatry). Basel: Karger.

Wingbermühle, E., Egger, J., van der Burgt, I., & Verhoeven, W. (2009). Neuropsychological and behavioral aspects of Noonan syndrome. Hormone Research, 72(Suppl 2), 15–23. doi:10.1159/000243774.CrossRef

Wingbermühle, E., Egger, J. I., Verhoeven, W. M., van der Burgt, I., & Kessels, R. P. (2012a). Affective functioning and social cognition in Noonan syndrome. Psychological Medicine, 42, 419–426. doi:10.1017/S0033291711001115.PubMedCrossRef

Wingbermühle, E., Roelofs, R. L., van der Burgt, I., Souren, P. M., Verhoeven, W. M., Kessels, R. P., et al. (2012b). Cognitive functioning of adults with Noonan syndrome: a case-control study. Genes, Brain and Behavior, 11(7), 785–793. doi:10.1111/j.1601-183X.2012.00821.x.CrossRef

Wood, A., Massarano, A., Super, M., & Harrington, R. (1995). Behavioural aspects and psychiatric findings in Noonan's syndrome. Archives of Disease in Childhood, 72(2), 153–155.PubMedPubMedCentralCrossRef

Yoon, G., Rosenberg, J., Blaser, S., & Rauen, K. A. (2007). Neurological complications of cardio-facio-cutaneous syndrome. Developmental Medicine and Child Neurology, 49(12), 894–899. doi:10.1111/j.1469-8749.2007.00894.x.PubMedCrossRef

Zarate, Y. A., Lichty, A. W., Champion, K. J., Clarkson, L. K., Holden, K. R., & Matheus, M. G. (2013). Unique cerebrovascular anomalies in Noonan syndrome with RAF1 mutation. Journal of Child Neurology, 29(8), NP13–NP17. doi:10.1177/0883073813492384.PubMedCrossRef

Titel: Neuropsychological Functioning in Individuals with Noonan Syndrome: a Systematic Literature Review with Educational and Treatment Recommendations
verfasst von: Elizabeth I. Pierpont
Publikationsdatum: 01.06.2016
Verlag: Springer International Publishing
Erschienen in: Journal of Pediatric Neuropsychology / Ausgabe 1-2/2016
Print ISSN: 2199-2681
Elektronische ISSN: 2199-2673
DOI: https://doi.org/10.1007/s40817-015-0005-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1-2/2016

Effects of Cranial Radiation on Structural and Functional Brain Development in Pediatric Brain Tumors

Introduction to the Special Issue for Journal of Pediatric Neuropsychology: Topical Issues for Pediatric Neuropsychologists

Principles and Practice of a Neuropsychological Approach to Conducting Independent Educational Evaluations

TBI and Concussions in Student Athletes: How do Severity of Injury, Age, and Gender Influence Recovery

An Updated Systematic Review of Neuroimaging Studies of Children and Adolescents with Perinatally Acquired HIV

Improving Educational Outcomes in Fetal Alcohol Spectrum Disorder Through Interagency Collaboration